Saida Yu, Homma Noriyuki, Hama Hitomi, Ueno Mitsuhiro, Imai Naofumi, Nishi Shinichi, Gejyo Fumitake
Department of Internal Medicine, Niigata Prefectural Shibata Hospital, Japan.
Nihon Jinzo Gakkai Shi. 2010;52(1):73-9.
A 78-year-old-man was admitted to our hospital because of renal insufficiency 20 months after the onset of autoimmune pancreatitis. He had cerebral infarction and prostatic hypertrophy as complications. He had been previously diagnosed with autoimmune pancreatitis (AIP). The initial therapy was started with oral prednisolone at the dose of 0.8 mg/kg (40 mg/day). Prednisolone had been tapered off gradually through a one-year period. Four months later from terminating prednisolone, a follow-up CT showed multiple low-density areas in both kidneys without swelling of the pancreas. Furthermore, 4 months later, laboratory findings showed progressive renal insufficiency. On admission, BP was 167/77 mmHg, and the bilateral submaxillary glands were swollen. He did not have pretibial edema. Laboratory findings were as follows. BUN 55.9 mg/dL, Cre 6.17 mg/dL, Amy 65 mg/dL, TP/Alb 9.5/4 g/dL, gamma-gl 43.7%, IgG/IgA/IgM 3,395/112/74 mg/dL, IgG4 1,460 mg/dL, urinary protein 1.38 g/day, and 24 hr-Ccr 11.8 mL/min/1.73 m2. Percutaneous renal needle biopsy was conducted. Light microscopic findings demonstrated tubulointerstitial nephritis (TIN) and membranous change. Immunofluorescent microscopic findings indicated diffuse deposition of IgG2 and IgG4 in the renal interstitium. On the basis of these findings, the condition was diagnosed as IgG4-related tubulointerstitial nephritis. As renal insufficiency was progressing, hemodialysis was started soon after admission and oral prednisolone was also started at the dose of 0.4 mg/kg (20 mg/day). However, improvement of renal function has not been obtained and hemodialysis and prednisolone tapering are still being conducted. This case showed severe tubulointerstitial nephritis requiring hemodialysis after a cure for autoimmune pancreatitis. IgG4-related renal disease rarely needs hemodialysis. This case indicates that the prognosis of IgG4-related systemic disease is not necessarily good and further accumulation of cases is required.
一名78岁男性在自身免疫性胰腺炎发病20个月后因肾功能不全入院。他有脑梗死和前列腺肥大等并发症。他此前已被诊断为自身免疫性胰腺炎(AIP)。初始治疗以0.8mg/kg(40mg/天)的口服泼尼松龙开始。泼尼松龙在一年时间内逐渐减量。停用泼尼松龙4个月后,随访CT显示双肾多个低密度区,胰腺无肿大。此外,4个月后,实验室检查结果显示肾功能不全进展。入院时,血压为167/77mmHg,双侧颌下腺肿大。他没有胫前水肿。实验室检查结果如下:尿素氮55.9mg/dL,肌酐6.17mg/dL,淀粉酶65mg/dL,总蛋白/白蛋白9.5/4g/dL,γ-球蛋白43.7%,免疫球蛋白G/免疫球蛋白A/免疫球蛋白M 3395/112/74mg/dL,免疫球蛋白G4 1460mg/dL,尿蛋白1.38g/天,24小时肌酐清除率11.8mL/min/1.73m²。进行了经皮肾穿刺活检。光镜检查结果显示肾小管间质性肾炎(TIN)和膜性改变。免疫荧光显微镜检查结果表明免疫球蛋白G2和免疫球蛋白G4在肾间质中弥漫性沉积。基于这些发现,该病情被诊断为免疫球蛋白G4相关性肾小管间质性肾炎。由于肾功能不全在进展,入院后不久开始血液透析,同时也开始以0.4mg/kg(20mg/天)的剂量口服泼尼松龙。然而,肾功能尚未得到改善,血液透析和泼尼松龙减量仍在进行。该病例显示在自身免疫性胰腺炎治愈后出现严重的肾小管间质性肾炎需要血液透析。免疫球蛋白G4相关性肾病很少需要血液透析。该病例表明免疫球蛋白G4相关性全身性疾病的预后不一定良好,需要进一步积累病例。